ROS to the rescue

Shampa Chatterjee and Aron B. Fisher

Institute for Environmental Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104

OVERPRODUCTION OF REACTIVE OXYGEN SPECIES (ROS) in biological systems has been associated with the initiation or aggravation of diverse pathological states (14, 19). The presumed mechanism is through the ability of ROS to induce biochemical alterations in macromolecules such as DNA, lipids, and proteins (4, 14, 17). It has been known for some time that ROS, produced physiologically by leukocytes and macrophages as a bactericidal mechanism of host defense, can also damage surrounding tissue. These effects and the cell damage caused by exogenously applied oxidants led to emphasis on the toxic effects of ROS. However, it is becoming increasingly evident that ROS also serve as physiological intracellular signaling molecules (9, 15) because they can, even at low concentrations, activate transcription factors, such as NF-{kappa}B, and alter mitogenic signals that affect cell growth, differentiation, and other cellular responses (9, 12). Milla et al., in one of the current articles in focus (Ref. 10, see p. L706 in this issue), take this concept a step further and cast ROS in a protective role where they reduced tissue damage and organ dysfunction in a model of lung inflammation (10). According to their interpretation, oxidants can control inflammation by inducing apoptosis of lymphocytic T cells, thereby decreasing production of proinflammatory cytokines. They postulate a balance between inflammation-mediated oxidative damage to tissues and oxidant-induced protective mechanisms as the most desirous state.

The immunologic model used by Milla et al. (10) is that of bone marrow transplant, following standard clinical procedures of irradiation and introduction of donor T cells at the time of transplant. The lung is an appropriate focus for this study since it is a target organ of the graft-vs.-host reaction in bone marrow transplant (11). Damage to the lung after bone marrow transplantation could occur either as a result of irradiation-induced oxidant injury or from proinflammatory cytokines released by T lymphocytes derived from the donor bone marrow graft. The T cells may attack tissues of the host that are recognized as foreign (8). Milla et al. (10) show that these pathways interact. Thus, whereas the inhibition of radical generation reduces oxidative damage and cellular apoptosis, it also decreases apoptosis in T lymphocytes, resulting in an exaggerated and detrimental immune response.

NADPH oxidase is a major source of ROS associated with oxidative stress in the lung. This enzyme complex is found in endothelium and other lung cells but is expressed at especially high levels in neutrophils, monocytes, and alveolar macrophages. Cell stimulation during microbial attack or other insults results in the translocation of the cystolic components of NADPH oxidase to the cell membrane where they assemble with the membrane components to form an electron transfer system that catalyzes the reduction of molecular oxygen to superoxide anion (O2·) while oxidizing NADPH. Increased O2 utilization and increased O2· production are the major characteristics of the "oxidative burst" that results from NADPH oxidase activation. O2· is converted to hydrogen peroxide (H2O2) in a reaction catalyzed by superoxide dismutases (1, 16). Oxidants are also produced by enzymes contained in certain intracellular granules. Azurophilic granules release myeloperoxidase (MPO) that, upon neutrophilic activation, catalyzes a reaction between H2O2 and chloride to produce hypochlorous acid, a highly potent oxidant (5). A similar enzyme, eosinophilic peroxidase, is released from eosinophilic granules and results in production of HOBr (13).

These oxidants have an important role in lung inflammation. T lymphocytes, mast cells, and other cells released by bone marrow in noninfectious inflammatory disorders are recruited to the lung alveoli. Activation of these cells results in the release of inflammatory cytokines and chemokines such as TNF-{alpha}, IFN-{gamma}, monocyte chemoattractant protein-1 (MCP-1), and macrophage inflammatory protein-{alpha}, which induce airway inflammation characterized by apoptosis, pulmonary edema, and necrosis (2, 3). T lymphocytes lodged in inflamed airways appear to be resistant to apoptosis, and their persistence is a major contributor to lung injury. Thus an agent capable of promoting T cell apoptosis could be beneficial in this experimental condition. Milla et al. (10) show that ROS can play the role of T cell apoptosis promoting agent. The evidence for this effect is the reduced propidium iodide and annexin V antibody staining in cells of the bronchoalveolar lavage fluid (BALF) of MPO–/– mice where oxidant generation after bone marrow transplant presumably was lower than that of wild-type mice.

MPO and associated oxidants convert nitrites and peroxides to nitrating agents for lipids and proteins. Milla et al. (10) show that protein nitrotyrosine formation is decreased in MPO–/– mice compatible with decreased oxidative/nitrosative stress. On the other hand, MPO–/– mice had increased alveolar epithelial type II cell injury and death as well as increased T cell-dependent inflammatory response, as indicated by elevated levels of TNF-{alpha} and MCP-1 in the BALF. The implication is that the possible beneficial reduction in oxidative damage to cells by absence of MPO-derived oxidants is overcome by the increased immune response. The results further imply that oxidants have an important role in T cell apoptosis but that nonoxidant mechanisms play the greater role in alveolar type II cell injury.

Why does the absence of MPO result in increased inflammation? Milla et al. (10) show that a possible mechanism is decreased apoptosis of T cells and macrophages. The premise is that these inflammatory cells are normally "controlled" by the conflagration of inflammation, but in the absence of MPO, have increased survival. That such enhanced inflammation is also observed when a major source of ROS is compromised, as in NADPH-oxidase gene-targeted mice, is compatible with an important role for ROS-induced apoptosis in controlling injury related to inflammation (18). Thus ROS and other oxidants can, by reducing the number of inflammatory cells, control the extent of tissue damage and lung dysfunction (6, 7, 18).

Although the experimental model studied by Milla et al. (10) provides interesting insights into the role of oxidant/antioxidant balance in disease, the application of the findings may be limited to bone marrow transplant cases where excessive numbers of T cells are a major contributor to pathophysiology. A possible complicating factor for interpretation of the results is the role of antioxidant defenses in these mice. Antioxidant defenses may be altered in the gene-targeted mice and also could be affected by the irradiation associated with the bone marrow transplantation protocol. Despite these limitations, the results raise interesting possibilities in terms of therapy of inflammatory disorders. Because optimal levels of ROS induce apoptosis of T cells and can modify the inflammatory response at otherwise subtoxic concentrations, the controlled use of ROS represents a possible therapeutic tool against inflammatory diseases. Of course, the challenge would be to discover and maintain the appropriate level of ROS.


    FOOTNOTES
 

Address for reprint requests and other correspondence: A. B. Fisher, Institute for Environmental Medicine, Univ. of Pennsylvania Medical Center, One John Morgan Bldg., Philadelphia, PA 19104-6068 (E-mail: abf{at}mail.med.upenn.edu)


    REFERENCES
 TOP
 REFERENCES
 

  1. Babior BM, Lambeth JD, and Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 397: 342–344, 2002.[CrossRef][ISI][Medline]
  2. Clark JG, Madtes DK, Martin TR, Hackman RC, Farrand AL, and Crawford SW. Idiopathic pneumonia after bone marrow transplantation: cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment. Crit Care Med 27: 1800–1806, 1999.[ISI][Medline]
  3. Cooke KR, Krenger W, Hill G, Martin TR, Kobzik L, Brewer J, Simmons R, Crawford JM, van den Brink MR, and Ferrara JL. Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation. Blood 92: 2571–2580, 1998.[Abstract/Free Full Text]
  4. Halliwell B and Gutteridge JMC. Free Radicals in Biology and Medicine. New York: Clarendon, 1999.
  5. Hawkins CL, Pattison DI, and Davies MJ. Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids 25: 259–274, 2003.[CrossRef][ISI][Medline]
  6. Jackson SH, Gallin JI, and Holland SM. The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med 182: 751–758, 1995.[Abstract]
  7. Koay MA, Christman JW, Segal BH, Venkatakrishnan A, Blackwell TR, Holland SM, and Blackwell TS. Impaired pulmonary NF-{kappa}B activation in response to lipopolysaccharide in NADPH oxidase-deficient mice. Infect Immun 69: 5991–5996, 2001.[Abstract/Free Full Text]
  8. Korngold R and Sprent J. T cell subsets and graft-versus-host disease. Transplantation 44: 335–339, 1987.[ISI][Medline]
  9. Martindale JL and Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192: 1–15, 2002.[CrossRef][ISI][Medline]
  10. Milla C, Yang S, Cornfield DN, Brennan ML, Hazen SL, Panoskaltsis-Mortari A, Blazar BR, and Haddad IY. Myeloperoxidase deficiency enhances inflammation after allogeneic marrow transplantation. Am J Physiol Lung Cell Mol Physiol 287: L706–L714, 2004.[Abstract/Free Full Text]
  11. Panoskaltsis-Mortari A, Taylor PA, Yaeger TM, Wangensteen OD, Bitterman PB, Ingbar DH, Vallera DA, and Blazar BR. The critical early proinflammatory events associated with idiopathic pneumonia syndrome in irradiated murine allogeneic recipients are due to donor T cell infusion and potentiated by cyclophosphamide. J Clin Invest 100: 1015–1027, 1997.[Abstract/Free Full Text]
  12. Sauer H, Wartenberg M, and Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11: 173–186, 2001.[CrossRef][ISI][Medline]
  13. Shen Z, Mitra SN, Wu W, Chen Y, Yang Y, Qin J, and Hazen SL. Eosinophil peroxidase catalyzes bromination of free nucleosides and double-stranded DNA. Biochemistry 40: 2041–2051, 2001.[CrossRef][ISI][Medline]
  14. Taniyama Y and Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42: 1075–1081, 2003.[Abstract/Free Full Text]
  15. Thannickal VJ and Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005–L1028, 2000.[Abstract/Free Full Text]
  16. Vignais PV. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci 59: 1428–1459, 2002.[CrossRef][ISI][Medline]
  17. Wu LL, Chiou CC, Chang PY, and Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 339: 1–9, 2004.[CrossRef][ISI][Medline]
  18. Yang S, Panoskaltsis-Mortari A, Shukla M, Blazar BR, and Haddad IY. Exuberant inflammation in nicotinamide adenine dinucleotide phosphate-oxidase-deficient mice after allogeneic marrow transplantation. J Immunol 168: 5840–5847, 2002.[Abstract/Free Full Text]
  19. Zhu X, Raina AK, Lee HG, Casadesus G, Smith MA, and Perry G. Oxidative stress signalling in Alzheimer's disease. Brain Res 1000: 32–39, 2004.[CrossRef][ISI][Medline]




This Article
Full Text (PDF)
Alert me when this article is cited
Alert me if a correction is posted
Citation Map
Services
Email this article to a friend
Similar articles in this journal
Similar articles in ISI Web of Science
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Google Scholar
Articles by Chatterjee, S.
Articles by Fisher, A. B.
Articles citing this Article
PubMed
PubMed Citation
Articles by Chatterjee, S.
Articles by Fisher, A. B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.